Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.6280
-0.0020 (-0.32%)
At close: May 15, 2026, 4:00 PM EDT
0.6350
+0.0070 (1.11%)
Pre-market: May 18, 2026, 4:49 AM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $14.82 million as of May 18, 2026. Its market cap has decreased by -80.15% in one year.
Market Cap
14.82M
Enterprise Value
-9.31M
1-Year Change
-80.15%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $14.82M, a decrease of -92.90%. That is a compound annual growth rate of -45.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 14.82M | -57.57% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 16.74M |
| Cocrystal Pharma | 16.54M |
| Ernexa Therapeutics | 15.89M |
| SeaStar Medical Holding | 15.79M |
| Cadrenal Therapeutics | 15.56M |
| Lexaria Bioscience | 14.68M |
| IN8bio | 14.67M |
| CytoMed Therapeutics | 13.73M |